These results follow similar findings from the companys ATTAIN-1 trial released earlier this month, which tested the drug on people who were overweight or obese without type 2 diabetes (in general, people without diabetes tend to lose more weight from GLP-1 therapy than those with diabetes)
Furthermore, FOXO4DRI could increase the percentage of type 2 alveolar epithelial cells (AEC2) and fibroblasts, and decrease the myofibroblasts in bleomycin (BLM)induced PF mouse model
doi:10.1016/j.fertnstert.2005.11.069 Fazelian S, Rouhani MH, Bank SS, Amani R
Khera M et al
This study highlights the essential protective role of the type II transmembrane serine protease (TTSP), hepsin, in mitigating acetaminophen-induced liver injury, particularly through its regulation of gap junction (GJ) abundance in response to reactive oxygen stress in the liver
Given the impactful role of KEAP1 in modulating NRF2 activity, modifying KEAP1 has emerged as a promising frontier in drug discovery